In addition MSI analysis on endometrial cancer, the most frequent tumour in female MSH6 mutation carriers might decrease its sensitivity, as it is known that the instability in these tumours is generally less pronounced (Wijnen et al, 1999; Hendriks et al, 2004). Here, MSH6 is linked to endometrial cancer.